UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Lowers Position in National Health Investors, Inc. (NYSE:NHI)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lessened its holdings in National Health Investors, Inc. (NYSE:NHI - Free Report) by 5.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 228,086 shares of the real estate investment trust's stock after selling 14,240 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.50% of National Health Investors worth $15,806,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Loomis Sayles & Co. L P lifted its holdings in shares of National Health Investors by 42.0% during the fourth quarter. Loomis Sayles & Co. L P now owns 639 shares of the real estate investment trust's stock worth $44,000 after purchasing an additional 189 shares during the period. Jones Financial Companies Lllp increased its position in shares of National Health Investors by 781.2% during the fourth quarter. Jones Financial Companies Lllp now owns 890 shares of the real estate investment trust's stock worth $62,000 after acquiring an additional 789 shares in the last quarter. Venturi Wealth Management LLC purchased a new stake in shares of National Health Investors in the fourth quarter worth approximately $63,000. NewEdge Advisors LLC bought a new stake in National Health Investors during the fourth quarter worth $83,000. Finally, KBC Group NV boosted its holdings in National Health Investors by 61.4% during the 4th quarter. KBC Group NV now owns 2,019 shares of the real estate investment trust's stock worth $140,000 after acquiring an additional 768 shares during the last quarter. Institutional investors and hedge funds own 62.51% of the company's stock.

National Health Investors Stock Performance

Shares of NHI traded down $0.40 during trading hours on Friday, hitting $72.53. The company's stock had a trading volume of 699,330 shares, compared to its average volume of 232,392. The business has a 50 day simple moving average of $73.97 and a two-hundred day simple moving average of $72.34. National Health Investors, Inc. has a 52-week low of $64.00 and a 52-week high of $86.13. The company has a debt-to-equity ratio of 0.92, a current ratio of 10.29 and a quick ratio of 10.29. The company has a market cap of $3.39 billion, a price-to-earnings ratio of 24.92, a PEG ratio of 4.42 and a beta of 0.78.

National Health Investors (NYSE:NHI - Get Free Report) last released its quarterly earnings data on Monday, May 5th. The real estate investment trust reported $1.15 earnings per share for the quarter, beating analysts' consensus estimates of $1.13 by $0.02. National Health Investors had a net margin of 38.53% and a return on equity of 10.11%. The business had revenue of $68.87 million during the quarter, compared to analyst estimates of $85.13 million. During the same period in the previous year, the business earned $1.10 EPS. National Health Investors's revenue was up 9.6% compared to the same quarter last year. On average, equities analysts expect that National Health Investors, Inc. will post 4.41 earnings per share for the current fiscal year.

National Health Investors Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 1st. Investors of record on Monday, June 30th will be issued a dividend of $0.90 per share. The ex-dividend date of this dividend is Monday, June 30th. This represents a $3.60 dividend on an annualized basis and a yield of 4.96%. National Health Investors's dividend payout ratio (DPR) is 114.29%.

Wall Street Analyst Weigh In

Several research analysts have weighed in on the company. Truist Financial boosted their price objective on National Health Investors from $70.00 to $76.00 and gave the stock a "hold" rating in a research report on Wednesday, March 19th. Wedbush reissued an "outperform" rating and set a $88.00 price objective on shares of National Health Investors in a report on Monday, March 17th. Three analysts have rated the stock with a hold rating and two have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $85.50.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.